Cytosorbents Corp 4
4 · Cytosorbents Corp · Filed Jun 9, 2016
Insider Transaction Report
Form 4
BARTLETT ROBERT HAWES
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2016-06-07+20,000→ 20,000 totalExercise: $4.69Exp: 2026-06-07→ Common Stock (20,000 underlying) - Award
Stock Option (right to buy)
2016-06-07+2,000→ 2,000 totalExercise: $8.07Exp: 2025-04-08→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]On April 8, 2015, the reporting person was granted an option to purchase 20,000 shares of common stock, which was to vest upon the satisfaction of certain performance criteria for the fiscal year ending December 31, 2015. The Board of Directors of CytoSorbents Corporation determined that 10% of such performance criteria was achieved during 2015, resulting in the vesting of 2,000 shares underlying this option.
- [F2]Such options were granted pursuant to the CytoSorbents Corporation 2014 Long-Term Incentive Plan, and shall vest upon achievement of certain performance goals as determined in the discretion of the Board of Directors of CytoSorbents Corporation.